This high-molecular-weight compound inactivates all the viruses it has been tested against (more than 20 viruses) thus halting their ability to enter cells and replicate: Adenovirus 1, Polio virus 1, Rhinovirus 2, HIV, Human rotavirus, Tacaribe, Rift Valley Fever, SARS-CoV (including COVID-19), Herpes Simplex 1, Influenza A (H3N2, H1N1, H5N1), Influenza B, Measles, Human parainfluenza 2, Human RSV, Vaccinia, Vesicular stomatitis, Dengue Fever, Yellow Fever, and West Nile virus. No drug is known to have similar properties.
This compound can be delivered to the alveolus and could be used as an effective treatment for COVID-19 victims and patients suffering from viral-related pneumonias. Indications are it can reduce destructive immune reactions now killing thousands of people.
Asymptomatic people spread COVID-19 when the virus is in their nasal passage or upper throat and they talk or sneeze. Using a nasal spray of this compound, these areas can be covered to inactivate the surface virus and cut viral transmission. Uninfected people using this nose spray could reject COVID-19 if the virus landed on a covered mucosal surface.
Website was built with Mobirise